Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens.

about

Distinct Immunologic Properties of Soluble Versus Particulate Antigens.

P2860

Q55270638-EA0167DA-0322-4A44-83EB-27A69067A149

P2860

Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens.

Item

http://www.wikidata.org/entity/Q47137438

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Design and evaluation of the i ...... formulation of viral antigens.

@en

Design and evaluation of the i ...... formulation of viral antigens.

@nl

type

Item

label

Design and evaluation of the i ...... formulation of viral antigens.

@en

Design and evaluation of the i ...... formulation of viral antigens.

@nl

prefLabel

Design and evaluation of the i ...... formulation of viral antigens.

@en

Design and evaluation of the i ...... formulation of viral antigens.

@nl

P1476

Design and evaluation of the i ...... formulation of viral antigens.

@en

P2093

Adam A Walters

http://www.w3.org/2001/XMLSchema#string

Felix A Rey

http://www.w3.org/2001/XMLSchema#string

Thomas Krey

http://www.w3.org/2001/XMLSchema#string

Till Rümenapf

http://www.w3.org/2001/XMLSchema#string

Victor Riitho

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccine-induced antibodies linked to bovine neonatal pancytopenia (BNP) recognize cattle major histocompatibility complex class I (MHC I)

Viral Dose and Immunosuppression Modulate the Progression of Acute BVDV-1 Infection in Calves: Evidence of Long Term Persistence after Intra-Nasal Infection

Recovery of cytopathogenic and noncytopathogenic bovine viral diarrhea viruses from cDNA constructs

The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule

Dendritic cells and the control of immunity

Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites

Programming the magnitude and persistence of antibody responses with innate immunity.

Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.

Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections.

Vaccination of cattle against bovine viral diarrhoea.

P2888

s41598-017-13915-x

P304

13743

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-13915-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Satyanarayana Somavarapu

P577

2017-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092262018

http://www.w3.org/2001/XMLSchema#string

P698

29062078

http://www.w3.org/2001/XMLSchema#string

P932

5653838

http://www.w3.org/2001/XMLSchema#string

Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens.

about

P2860

P2860

Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932